Robert R. Luther

1.7k total citations
30 papers, 1.2k citations indexed

About

Robert R. Luther is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert R. Luther has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert R. Luther's work include Blood Pressure and Hypertension Studies (10 papers), Hormonal Regulation and Hypertension (6 papers) and Pain Mechanisms and Treatments (4 papers). Robert R. Luther is often cited by papers focused on Blood Pressure and Hypertension Studies (10 papers), Hormonal Regulation and Hypertension (6 papers) and Pain Mechanisms and Treatments (4 papers). Robert R. Luther collaborates with scholars based in United States, United Kingdom and South Korea. Robert R. Luther's co-authors include S. Scott Bowersox, Dawn McGuire, Martha Mayo, J. D. FELLMANN, David Ellis, Thomas Yearwood, Michael G. Byas‐Smith, David A. Bryce, Peter S. Staats and R. Presley and has published in prestigious journals such as JAMA, Brain Research and The American Journal of Medicine.

In The Last Decade

Robert R. Luther

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert R. Luther United States 16 470 366 267 260 209 30 1.2k
Jean‐François Giudicelli France 27 363 0.8× 336 0.9× 84 0.3× 1.2k 4.4× 351 1.7× 73 2.0k
M. Gellai United States 21 386 0.8× 561 1.5× 69 0.3× 498 1.9× 109 0.5× 40 1.4k
L Triner United States 17 519 1.1× 318 0.9× 188 0.7× 444 1.7× 359 1.7× 77 1.4k
Kumi Nakamura Japan 22 286 0.6× 330 0.9× 130 0.5× 191 0.7× 183 0.9× 64 1.0k
Pierre Peeters Netherlands 19 193 0.4× 120 0.3× 255 1.0× 223 0.9× 145 0.7× 37 1.0k
Noboru Hatakeyama Japan 21 330 0.7× 139 0.4× 129 0.5× 275 1.1× 160 0.8× 69 1.0k
F Lhoste France 19 184 0.4× 184 0.5× 38 0.1× 254 1.0× 96 0.5× 56 906
Shanglong Yao China 24 396 0.8× 196 0.5× 77 0.3× 58 0.2× 179 0.9× 53 1.5k
Mariagnes Verosky United States 15 334 0.7× 220 0.6× 44 0.2× 150 0.6× 76 0.4× 51 777
Jiro Nakano United States 23 289 0.6× 328 0.9× 21 0.1× 408 1.6× 239 1.1× 103 1.6k

Countries citing papers authored by Robert R. Luther

Since Specialization
Citations

This map shows the geographic impact of Robert R. Luther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert R. Luther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert R. Luther more than expected).

Fields of papers citing papers by Robert R. Luther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert R. Luther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert R. Luther. The network helps show where Robert R. Luther may publish in the future.

Co-authorship network of co-authors of Robert R. Luther

This figure shows the co-authorship network connecting the top 25 collaborators of Robert R. Luther. A scholar is included among the top collaborators of Robert R. Luther based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert R. Luther. Robert R. Luther is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staats, Peter S., Thomas Yearwood, Steven G. Charapata, et al.. (2004). Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS. JAMA. 291(1). 63–63. 404 indexed citations
2.
Tumlin, James A., Lala M. Dunbar, Suzanne Oparil, et al.. (2000). Fenoldopam, a Dopamine Agonist, for Hypertensive Emergency: A Multicenter Randomized Trial. Academic Emergency Medicine. 7(6). 653–662. 55 indexed citations
3.
Mathur, Vandana, Suzanne K. Swan, Lawrence J. Lambrecht, et al.. (1999). The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects. Critical Care Medicine. 27(9). 1832–1837. 129 indexed citations
4.
Samii, Amir, et al.. (1999). Effects of an N-type Calcium Channel Antagonist (SNX 111; Ziconotide) on Calcium-45 Accumulation Following Fluid-Percussion Injury. Journal of Neurotrauma. 16(10). 879–892. 32 indexed citations
5.
Taylor, Addison A., et al.. (1999). Sustained Hemodynamic Effects of the Selective Dopamine‐1 Agonist, Fenoldopam, during 48‐Hour Infusions in Hypertensive Patients: A Dose‐Tolerability Study. The Journal of Clinical Pharmacology. 39(5). 471–479. 8 indexed citations
6.
Ellis, David, Robert R. Luther, J. D. FELLMANN, Vandana Mathur, & Dawn McGuire. (1998). TREATMENT OF HYPERTENSIVE EMERGENCIES WITH FENOLDOPAM, A PERIPHERALLY ACTING DOPAMINE (DA1) RECEPTOR AGONIST. Critical Care Medicine. 26(Supplement). 23A–23A. 2 indexed citations
7.
Brose, William G., et al.. (1997). Use of Intrathecal SNX-111, a Novel, N-Type, Voltage-Sensitive, Calcium Channel Blocker, in the Management of Intractable Brachial Plexus Avulsion Pain. Clinical Journal of Pain. 13(3). 256–259. 112 indexed citations
8.
McGuire, Dawn, S. Scott Bowersox, J. D. FELLMANN, & Robert R. Luther. (1997). Sympatholysis After Neuron-Specific, N-Type, Voltage-Sensitive Calcium Channel Blockade: First Demonstration of N-Channel Function in Humans. Journal of Cardiovascular Pharmacology. 30(3). 400–403. 66 indexed citations
9.
Bowersox, S. Scott, Tejinder Singh, & Robert R. Luther. (1997). Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in rats. Brain Research. 747(2). 343–347. 44 indexed citations
10.
Cheung, Deanna G., et al.. (1991). Antihypertensive dose-response relationships: Studies with the selective α1-blocking agent terazosin. American Heart Journal. 122(3). 905–910. 7 indexed citations
11.
Neutel, Joel M., Robert R. Luther, R. Boger, & Michael A. Weber. (1991). Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat. American Heart Journal. 122(4). 1094–1100. 34 indexed citations
12.
Glassman, Harriet N., et al.. (1990). Clinical Pharmacology of Enalkiren, A Novel, Dipeptide Renin Inhibitor. Journal of Cardiovascular Pharmacology. 16(Supplement 4). S76–S81. 16 indexed citations
13.
Bursztyn, Michael, Haralambos Gavras, Charles P. Tifft, et al.. (1990). Effects of a Novel Renin Inhibitor in Patients with Essential Hypertension. Journal of Cardiovascular Pharmacology. 15(3). 493–500. 14 indexed citations
14.
Anderson, Pamela W., Patrick Shu‐Hang Yung, Morris Schambelan, et al.. (1990). Effects of renin inhibition in systemic hypertension. The American Journal of Cardiology. 66(19). 1342–1347. 10 indexed citations
15.
Tolman, Keith G., et al.. (1989). Toxicity of uricosuric diuretics in rat hepatocyte culture. Biochemical Pharmacology. 38(7). 1181–1184. 3 indexed citations
16.
Luther, Robert R., et al.. (1989). The effects of terazosin and methyclothiazide on blood pressure and serum lipids. American Heart Journal. 117(4). 842–847. 20 indexed citations
17.
Luther, Robert R., et al.. (1988). A Comparison of Carteolol and Nadolol in the Treatment of Stable Angina Pectoris. The Journal of Clinical Pharmacology. 28(7). 634–639. 3 indexed citations
18.
Luther, Robert R., et al.. (1987). Pharmacologic Effects of A‐49816, a New High‐Ceiling Diuretic. The Journal of Clinical Pharmacology. 27(10). 794–801.
19.
Luther, Robert R., et al.. (1986). Efficacy of terazosin as an antihypertensive agent. The American Journal of Medicine. 80(5). 73–76. 20 indexed citations
20.
Luther, Robert R., et al.. (1986). Carteolol Treatment of Essential Hypertension: A Long-Term Study of Safety and Efficacy. Journal of International Medical Research. 14(4). 175–184. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐François Giudicelli Breakdown of academic impact, for papers by M. Gellai Breakdown of academic impact, for papers by L Triner Breakdown of academic impact, for papers by Kumi Nakamura Breakdown of academic impact, for papers by Pierre Peeters Breakdown of academic impact, for papers by Noboru Hatakeyama Breakdown of academic impact, for papers by F Lhoste Breakdown of academic impact, for papers by Shanglong Yao Breakdown of academic impact, for papers by Mariagnes Verosky Breakdown of academic impact, for papers by Jiro Nakano
Rankless by CCL
2026